The role of cetuximab in the management of head and neck cancers

Author： Kabolizadeh Peyman   Kubicek Gregory J   Heron Dwight E   Ferris Robert L   Gibson Michael K  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.12, Iss.4, 2012-04, pp. : 517-528

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of cetuximab in the treatment of squamous cell cancer of the head and neck

By Burtness Barbara  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 8, 2005-08 ,pp. : 1085-1093

Informa Healthcare

Access to resources Recommend Favorite

Zalutumumab in head and neck cancer

By Schick Ulrike   Gujral Dorothy M   Richards Tom M   Harrington Kevin J   Nutting Christopher M  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

Immune alterations and immunotherapy prospects in head and neck cancer

By Varilla Vincent  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1241-1256

Informa Healthcare

Access to resources Recommend Favorite

STAT3 as a therapeutic target in head and neck cancer

By Leeman Rebecca J   Lui Vivian Wai Yan   Grandis Jennifer Rubin  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite

Selenium and immunocompetence in patients with head and neck cancer

By Kiremidjian-Schumacher L.   Roy M.   Glickman R.   Schneider K.   Rothstein S.   Cooper J.   Hochster H.   Kim M.   Newman R.  

Biological Trace Element Research, Vol. 73, Iss. 2, 2000-02 ,pp. : 97-111

Humana Press, Inc

Access to resources Recommend Favorite